A detailed history of Herold Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Herold Advisors, Inc. holds 37,279 shares of MRK stock, worth $3.66 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
37,279
Previous 37,209 0.19%
Holding current value
$3.66 Million
Previous $4.61 Million 8.1%
% of portfolio
0.94%
Previous 1.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $7,780 - $9,027
70 Added 0.19%
37,279 $4.23 Million
Q2 2024

Jul 24, 2024

BUY
$123.8 - $132.96 $5,447 - $5,850
44 Added 0.12%
37,209 $4.61 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $71,001 - $82,732
-627 Reduced 1.66%
37,165 $4.9 Million
Q4 2023

Feb 02, 2024

BUY
$100.18 - $109.02 $85,553 - $93,103
854 Added 2.31%
37,792 $4.12 Million
Q3 2023

Nov 08, 2023

BUY
$102.95 - $114.33 $59,299 - $65,854
576 Added 1.58%
36,938 $3.8 Million
Q2 2023

Jul 14, 2023

BUY
$108.61 - $118.38 $164,326 - $179,108
1,513 Added 4.34%
36,362 $4.2 Million
Q1 2023

Apr 19, 2023

BUY
$102.94 - $114.86 $369,039 - $411,773
3,585 Added 11.47%
34,849 $3.71 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $218,162 - $279,714
2,495 Added 8.67%
31,264 $3.47 Million
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $333,386 - $374,522
3,944 Added 15.89%
28,769 $2.48 Million
Q2 2022

Jul 15, 2022

BUY
$83.49 - $94.64 $15,111 - $17,129
181 Added 0.73%
24,825 $2.26 Million
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $260,886 - $292,437
3,549 Added 16.82%
24,644 $2.02 Million
Q4 2021

Jan 20, 2022

BUY
$72.28 - $90.54 $67,003 - $83,930
927 Added 4.6%
21,095 $1.62 Million
Q3 2021

Nov 03, 2021

BUY
$71.68 - $78.83 $1.45 Million - $1.59 Million
20,168 New
20,168 $1.51 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Herold Advisors, Inc. Portfolio

Follow Herold Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.